Welcome to our dedicated page for Neogen news (Ticker: NEOG), a resource for investors and traders seeking the latest updates and insights on Neogen stock.
Neogen Corporation (NASDAQ: NEOG) generates a steady flow of news related to food safety, animal safety, and global food security. As a Lansing, Michigan-based manufacturer of diagnostics and related products, Neogen regularly issues updates on its financial performance, segment trends, and strategic actions that affect the Food Safety and Animal Safety markets.
On this page, readers can follow earnings releases where Neogen reports revenue, segment performance, gross margin, and non-GAAP measures such as adjusted EBITDA. These updates often break out results for the Food Safety and Animal Safety segments, discuss core revenue trends versus divestitures and discontinued product lines, and provide commentary on product categories like pathogen detection, indicator testing, culture media, biosecurity, and genomics.
Neogen’s news flow also includes announcements about leadership changes, such as the appointment of a new President and Chief Executive Officer, Chief Financial Officer, and senior commercial and business unit leaders. Board transitions, including director retirements and new director appointments, are disclosed through both press releases and related SEC filings.
Sector-specific items appear in Neogen’s news as well, including collaborations in equine health and vaccine offerings such as BotVax B for botulism Type B in horses. The company also announces participation in investor conferences and the timing of quarterly earnings calls and webcasts.
By reviewing the NEOG news feed on this page, investors and observers can track how Neogen describes its progress in food safety, livestock, and pet health and wellness, as well as its strategic transformation efforts, restructuring actions, and capital allocation decisions over time.
Neogen (NEOG) will participate in the 2024 RBC Capital Markets Global Healthcare Conference in New York. John Adent, the CEO, will present on May 14, 2024, at 4:05 PM Eastern Time. Investors can access the webcast and presentation materials on Neogen's Investor Relations website.
Neogen® (NASDAQ: NEOG) is celebrating 40 years of Petrifilm, a groundbreaking solution that has revolutionized microbiological testing in the food safety industry. With over 2.85 billion plates used worldwide and 105+ global validations, Petrifilm has significantly increased productivity, reduced testing time, and saved space in laboratories. Neogen remains committed to providing high-quality, innovative solutions to maintain its position as a global leader in food safety.
Neogen® introduced the Neogen Molecular Detection Assay 2 – Salmonella Enteritidis/Salmonella Typhimurium (MDA2SEST) to add to their pathogen testing platform, helping enhance food safety in the poultry industry. The new assay offers improved accuracy, reduced time to results, and a streamlined workflow. It detects specific Salmonella serotypes, aiding in reducing foodborne illness. The product has been approved by the AOAC® Research Institute, and it is part of the award-winning Neogen Molecular Detection System platform.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.